Zobrazeno 1 - 10
of 38
pro vyhledávání: '"David, Topolsky"'
Autor:
Stuthi Perimbeti, Kristine Ward, Kevin Ye Hou, Pamela Crilley, Sabarina Ramanathan, Michael Styler, Adonas Woodard, David Topolsky, Daniel Kyung
Publikováno v:
Blood. 132:5889-5889
Introduction: Case reports have suggested that there is an increased risk of hematological malignancies with sickle cell disease (SCD). We aimed to investigate the prevalence and mortality of select hematological malignancies, including: acute myeloi
Autor:
David Topolsky
Publikováno v:
Oncology Times. 40:1
Autor:
David Topolsky
Publikováno v:
Oncology Times. 40:1
Autor:
David Topolsky, Kristine Ward, Erin R. Reichenberger, Nicole Simpkins, Pamela Crilley, Robert J. Schwartzman, Guillermo M. Alexander, Noah Lindenberg
Publikováno v:
CNS Neuroscience & Therapeutics. 15:118-127
High dose cyclophosphamide (HDC) has been successfully used for the treatment of a variety of autoimmune diseases. In this study, we sought to determine whether the use of high dose cyclophosphamide provided stabilization of relapsing remitting MS (R
Autor:
S Hoch, Isadore Brodsky, A. Pradhan, Pamela Crilley, David Topolsky, Michael Styler, Douglas E. Gladstone, A Huppert, Ann A. Prestrud
Publikováno v:
Lupus. 11:405-410
Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here w
Autor:
Daniela M. Albu, Maurie Markman, Diane Denny, Pamela Crilley, David Topolsky, Ankur R. Parikh, Scott Hartman, Brandon Bosch
Publikováno v:
Blood. 128:5990-5990
BACKGROUND : In patients with hematologic malignancies symptoms related to the disease and its treatment remain a major problem in patient care. With the advent of new treatment including immunotherapy and targeted therapies the potential for prolong
Autor:
King Rs, Isadore Brodsky, Meglathery Sb, Ener Ra, David Topolsky, Kahn Sb, Pamela Crilley, Michael Styler, Cuhaci B
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 24:19-25
Administration of granulocyte colony-stimulating factor to patients undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplantation accelerates neutrophil recovery and decreases hospitalization time. The optimal timing for
Autor:
Michael Styler, Maneesh Jain, David Cho, Marc J. Kim, Pamela Crilley, Kristine Ward, David Topolsky
Publikováno v:
Blood. 126:2001-2001
Introduction: Autologous stem cell transplantation after high dose chemotherapy has been shown to increase survival in patients with multiple myeloma. Studies have shown prolongation of median overall survival by 12 months. The standard conditioning
Autor:
David Topolsky, Kristine Ward, A.M. Weber, P. Pillai, R. Mullaney, Pamela Crilley, Michael Styler
Publikováno v:
Biology of Blood and Marrow Transplantation. 17(2)
Autor:
Arthur S. Patchefsky, Harold L. Paz, Pamela Crilley, David Topolsky, Isadore Brodsky, William X. Coll
Publikováno v:
Respiration. 60:109-114
While half of all patients receiving bone marrow transplantation (BMT) for malignancies and related diseases may achieve prolonged disease-free survival, 2-10% of patients undergoing allogeneic transplantation develop bronchiolitis obliterans (BrOb).